NCT00235118

Brief Summary

The objective of this study is to assess the safety and effectiveness of the Cordis Bilateral AAA device and its Delivery System compared to open surgical repair for the treatment of Abdominal Aortic Aneurysm (AAA).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Dec 1999

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 1999

Completed
5.9 years until next milestone

First Submitted

Initial submission to the registry

October 6, 2005

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 10, 2005

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2006

Completed
Last Updated

December 9, 2005

Status Verified

October 1, 2005

First QC Date

October 6, 2005

Last Update Submit

December 8, 2005

Conditions

Outcome Measures

Primary Outcomes (2)

  • Primary success is defined as freedom from all of the following: rupture of aneurysm, enlargement of aneurysm > 0.5 cm on CT scan, with or without endoleak, as compared to any previous measurement, symptomatic aneurysm requiring treatment.

  • The absence of major complications at thirty days defined as arterial thrombosis, respiratory impairment, renal failure, myocardial infarction (M.I.) and stroke in combination with the absence of major complications at one year.

Secondary Outcomes (1)

  • · Technical success defined as the successful access and deployment of the device at the appropriate anatomic location with aneurysmal exclusion determined by angiography at the time of deployment.

Interventions

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Anatomic (stent-graft)
  • Aortic Aneurysm Diameter
  • \> 4.5 cm
  • Those aortic aneurysms \< 4.5 cm that are at least 1.5 times the diameter of the aorta with a size increase of 5 mm or greater over a six month period will also be included for possible treatment.
  • Aorto-iliac aneurysms in which the aortic aneurysm is \< 4.5 cm but the iliac artery aneurysms are \> 3.0 cm in diameter or there is evidence of recent expansion (5 mm or greater over a six month period) in iliac aneurysms \< 3.0 cm.
  • Saccular aortic aneurysms \> 3.0 cm.
  • Aortic Neck
  • Diameter \> 17 mm and \< 28 mm (Phase I)
  • Diameter \> 14 mm and \< 28 mm (Phase II)
  • Angulation Neck Length \< 45° \> 15 mm \<60° \> 25 mm
  • Iliac Arteries
  • Diameter \> 8 mm and \< 18 mm (Phase I and Phase II)
  • At least one common iliac artery with a cuff \> 15 mm.
  • Diameter Aortic Neck Common Iliac 26-28 mm 13-18 mm 23-25.9 mm 10-17 mm 20-22.9 mm 9-15 mm 17-19.9 mm 8-13 mm 14-16.9 mm 8-11mm
  • \*NOTE: An aortic diameter cannot be treated if the iliac diameter is not in the same range (e.g. 26-28 mm aortic necks must be in conjunction with 13-18 mm common iliacs).
  • +9 more criteria

You may not qualify if:

  • Anatomic (stent-graft)
  • Aortic Aneurysm Diameter
  • · \< 4.5 cm that are not at least 1.5 times the diameter of the aorta with evidence of a size increase of 5 mm or greater within a six month period.
  • Aorto-iliac Aneurysms
  • \< 3.0 cm in diameter unless evidence of recent expansion (5 mm or greater within a six month period).
  • The iliac portion of the aneurysm extending to the bifurcation bilaterally which would necessitate covering both internal iliac arteries with the device.
  • Aortic Neck
  • Diameter \< 17 mm and \> 28 mm (Phase I)
  • Diameter \< 14 and \>28 (Phase II)
  • Thrombus lined
  • Highly calcified
  • Iliac Arteries
  • \< 8 mm and \> 18 mm (native) (Phase I and Phase II)
  • Highly calcified (common)
  • Neither common iliac artery with a cuff \> 15 mm.
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mt. Sinai Hospital

New York, New York, 10029, United States

Location

MeSH Terms

Conditions

Aortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Michael Marin, MD

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 6, 2005

First Posted

October 10, 2005

Study Start

December 1, 1999

Study Completion

February 1, 2006

Last Updated

December 9, 2005

Record last verified: 2005-10

Locations